{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:45:39Z","timestamp":1790109939070,"version":"4.0.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.autrev.2024.103643","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T12:11:35Z","timestamp":1726747895000},"page":"103643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prolactin's paradox: Friend, foe, or both in immune regulation?"],"prefix":"10.1016","volume":"23","author":[{"given":"V\u00e2nia","family":"Borba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Carrera-Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele","family":"Zandman-Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103643_bb0005","first-page":"33","article-title":"Exacerbations of autoimmune diseases during pregnancy and postpartum","author":"Borba","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103643_bb0010","first-page":"145","article-title":"Pregnancy and autoimmune disease","volume":"119","author":"Merz","year":"2022","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.autrev.2024.103643_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1142723","article-title":"Sex and gender influence on immunity and autoimmunity","volume":"14","author":"Lahita","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.autrev.2006.10.001","article-title":"Gender and autoimmunity","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103643_bb0025","first-page":"9","article-title":"Prolactin and autoimmunity","author":"Borba","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12016-009-8185-3","article-title":"Prolactin and autoimmunity","volume":"40","author":"Jara","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/0004-2730000003002","article-title":"Challenges and pitfalls in the diagnosis of hyperprolactinemia","volume":"58","author":"Vilar","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.autrev.2024.103643_bb0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.tjog.2017.10.002","article-title":"Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia","volume":"56","author":"Kasum","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2024.103643_bb0045","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2024.103643_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1134\/S0006297919040011","article-title":"Prolactin receptor isoforms as the basis of tissue-specific action of prolactin in the norm and pathology","volume":"84","author":"Abramicheva","year":"2019","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.autrev.2024.103643_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101324","article-title":"Prolactin and autoimmunity: the hormone as an inflammatory cytokine","author":"Borba","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103643_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ccr3.1900","article-title":"Impact of hyperprolactinemia in a patient with polyautoimmunity","volume":"7","author":"Rojas","year":"2019","journal-title":"Clin Case Reports"},{"key":"10.1016\/j.autrev.2024.103643_bb0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1210\/rp.57.1.435","article-title":"Prolactin modulation of immune and inflammatory responses","volume":"57","author":"Yu-Lee","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.autrev.2024.103643_bb0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41574-019-0194-6","article-title":"Prolactin - a pleiotropic factor in health and disease","volume":"15","author":"Bernard","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.autrev.2024.103643_bb0075","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clim.2005.03.013","article-title":"Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes","volume":"116","author":"Chavez-Rueda","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-101","article-title":"Novel pebbles in the mosaic of autoimmunity","author":"Perricone","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2024.103643_bb0085","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4049\/jimmunol.178.3.1443","article-title":"Age-associated decline in effective immune synapse formation of CD4 + T cells is reversed by vitamin E supplementation","volume":"178","author":"Marko","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/cmi.2010.70","article-title":"Explosion of autoimmune diseases and the mosaic of old and novel factors","volume":"8","author":"Agmon-Levin","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/0167-5699(89)90245-4","article-title":"The mosaic of autoimmunity","author":"Shoenfeld","year":"1989","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2024.103643_bb0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08916939309019934","article-title":"The kaleidoscope of autoimmunity","volume":"15","author":"Shoenfeld","year":"1993","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2024.103643_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2018.12.003","article-title":"The kaleidoscope of autoimmunity \u2013 from genes to microbiome","author":"Shoenfeld","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0110","first-page":"11","article-title":"Prolactin and autoimmunity","author":"Shelly","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103643_bb0115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10067-015-2904-3","article-title":"Meta-analysis of associations between functional prolactin \u22121149 G\/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus","volume":"34","author":"Lee","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103643_bb0120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.autrev.2006.10.005","article-title":"Hyperprolactinemia and autoimmune diseases","volume":"6","author":"Orbach","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103643_bb0125","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1191\/096120301717164912","article-title":"Prolactin, a lymphocyte growth and survival factor","volume":"10","author":"Buckley","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103643_bb0130","first-page":"12","article-title":"The prevalence of autoimmune disorders in women: a narrative review","author":"Angum","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2024.103643_bb0135","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/jim-2022-002351","article-title":"Recent findings on hyperprolactinemia and its pathological implications: a literature review","volume":"70","author":"Ghoreshi","year":"2022","journal-title":"J Investig Med"},{"key":"10.1016\/j.autrev.2024.103643_bb0140","first-page":"33","article-title":"Prolactin and autoimmunity: the hormone as an inflammatory cytokine","author":"Borba","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103643_bb0145","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/er.2011-1040","article-title":"Molecular mechanisms of prolactin and its receptor","volume":"33","author":"Brooks","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.autrev.2024.103643_bb0150","first-page":"13","article-title":"Prolactin receptor signaling: a novel target for cancer treatment - exploring anti-PRLR signaling strategies","author":"Standing","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.autrev.2024.103643_bb0155","first-page":"2021","article-title":"Prolactin increases the frequency of follicular T helper cells with enhanced IL21 secretion and OX40 expression in lupus-prone MRL\/lpr mice","author":"Alem\u00e1n-Garc\u00eda","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2024.103643_bb0160","first-page":"15","article-title":"Hormones and B-cell development in health and autoimmunity","author":"Santana-S\u00e1nchez","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0165","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/a-1126-4272","article-title":"Immunomodulating effects depend on prolactin levels in patients with hyperprolactinemia","volume":"52","author":"Ewerman","year":"2020","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.autrev.2024.103643_bb0170","first-page":"7","article-title":"A combined computational and structural model of the full-length human prolactin receptor","author":"Bugge","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2024.103643_bb0175","first-page":"6","article-title":"Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms","author":"Taghi Khani","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.autrev.2024.103643_bb0180","first-page":"13","article-title":"The effect of prolactin on immune cell subsets involved in SLE pathogenesis","author":"Legorreta-Haquet","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0185","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.biopha.2004.04.007","article-title":"Prolactin as a modulator of B cell function: implications for SLE","volume":"58","author":"Peeva","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.autrev.2024.103643_bb0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.imlet.2005.05.014","article-title":"Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes","volume":"101","author":"Peeva","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2024.103643_bb0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1051\/jbio\/2022019","article-title":"Prolactin and its receptor: from animal models to pituitary pathophysiology","volume":"216","author":"Begon","year":"2022","journal-title":"Biol Aujourdhui"},{"key":"10.1016\/j.autrev.2024.103643_bb0200","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12026-016-8891-x","article-title":"Prolactin has a pathogenic role in systemic lupus erythematosus","volume":"65","author":"Jara","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2024.103643_bb0205","first-page":"99","article-title":"Prolactin triggers pro-inflammatory immune responses in peripheral immune cells","volume":"15","author":"Brand","year":"2004","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.autrev.2024.103643_bb0210","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0961203308089402","article-title":"Hormonal regulation of B-cell function and systemic lupus erythematosus","volume":"17","author":"Cohen-Solal","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103643_bb0215","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.molimm.2004.05.014","article-title":"Hormonal modulation of B cell development and repertoire selection","volume":"42","author":"Grimaldi","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1017115","article-title":"Prolactin promotes proliferation of germinal center B cells, formation of plasma cells, and elevated levels of IgG3 anti-dsDNA autoantibodies","volume":"13","author":"Carre\u00f3n-Talavera","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0225","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/art.24500","article-title":"Prolactin alters the mechanisms of B cell tolerance induction","volume":"60","author":"Saha","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103643_bb0230","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/14397595.2019.1620999","article-title":"Prolactin activates IRF1 and leads to altered balance of histone acetylation: implications for systemic lupus erythematosus","volume":"30","author":"Leung","year":"2020","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2024.103643_bb0235","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/icb.2008.29","article-title":"Prolactin can modulate CD4+ T-cell response through receptor-mediated alterations in the expression of T-bet","volume":"86","author":"Tomio","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2024.103643_bb0240","series-title":"Bronstein MD","author":"Glezer","year":"2022"},{"key":"10.1016\/j.autrev.2024.103643_bb0245","first-page":"46","article-title":"Hyperprolactinemia in women: diagnostic approach","author":"Glezer","year":"2024","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.autrev.2024.103643_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2008.05.006","article-title":"Neuroendocrine interactions in the immune system","volume":"252","author":"Taub","year":"2008","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.rdc.2004.10.004","article-title":"The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity","volume":"31","author":"Szyper-Kravitz","year":"2005","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.autrev.2024.103643_bb0260","first-page":"7","article-title":"Updated advances of linking psychosocial factors and sex hormones with systemic lupus erythematosus susceptibility and development","author":"Pan","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.autrev.2024.103643_bb0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11102-005-5082-5","article-title":"Prolactin and autoimmunity","volume":"8","author":"De Bellis","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.autrev.2024.103643_bb0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12016-009-8182-6","article-title":"Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models","volume":"40","author":"Saha","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0275","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12016-011-8256-0","article-title":"Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients","volume":"42","author":"Orbach","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0280","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/rheumatology\/kei115","article-title":"Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity","volume":"45","author":"Lea\u00f1os-Miranda","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103643_bb0285","first-page":"336","article-title":"Sex hormones and prolactin levels and their association with anti cardiolipin antibody in patients with systemic lupus erythematosus","volume":"17","author":"Raeisi","year":"2018","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0290","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1196\/annals.1422.024","article-title":"Prolactin levels are associated with lupus activity, lupus anticoagulant, and poor outcome in pregnancy","volume":"1108","author":"Jara","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2024.103643_bb0295","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/art.1780370605","article-title":"Breast-feeding and the onset of rheumatoid arthritis","volume":"37","author":"Brennan","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103643_bb0300","first-page":"264","article-title":"Breastfeeding-related onset, flare, and relapse of rheumatoid arthritis","volume":"59","author":"JS H","year":"2001","journal-title":"Nutr Rev"},{"key":"10.1016\/j.autrev.2024.103643_bb0305","first-page":"38","article-title":"Prolactin, autoimmunity, and motherhood: when should women avoid breastfeeding?","author":"Vieira Borba","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103643_bb0310","unstructured":"Breast-feeding and Postpartum Relapse in Women with Rheumatoid and Inflammatory Arthritis PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/10817553\/ (accessed July 14, 2024)."},{"key":"10.1016\/j.autrev.2024.103643_bb0315","first-page":"849","article-title":"Elevated prolactin levels in patients with rheumatoid arthritis: association with disease activity and structural damage","volume":"28","author":"Fojt\u00edkov\u00e1","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103643_bb0320","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/art.38746","article-title":"Increased expression of dopamine receptors in synovial fibroblasts from patients with rheumatoid arthritis: inhibitory effects of dopamine on interleukin-8 and interleukin-6","volume":"66","author":"Capellino","year":"2014","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.autrev.2024.103643_bb0325","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00393-002-0413-7","article-title":"Prolactin and thyroid hormones in patients with systemic sclerosis: correlations with disease manifestations and activity","volume":"61","author":"Shahin","year":"2002","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.autrev.2024.103643_bb0330","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3389\/fimmu.2017.00720","article-title":"Insight into the endocrine system and the immune system: a review of the inflammatory role of prolactin in rheumatoid arthritis and psoriatic arthritis","volume":"8","author":"Tang","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0335","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10072-023-07008-z","article-title":"The relationship between plasma prolactin levels and clinical manifestations with neuromyelitis optica spectrum disorders","volume":"45","author":"Liu","year":"2024","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2024.103643_bb0340","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archneurol.2009.132","article-title":"Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis","volume":"66","author":"Langer-Gould","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2024.103643_bb0345","first-page":"56","article-title":"Pregnancy and multiple sclerosis: an update on the disease modifying treatment strategy and a review of Pregnancy\u2019s impact on disease activity","author":"Varyt\u0117","year":"2020","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.autrev.2024.103643_bb0350","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1258\/om.2012.110014","article-title":"Pregnancy and multiple sclerosis","volume":"5","author":"Airas","year":"2012","journal-title":"Obstet Med"},{"key":"10.1016\/j.autrev.2024.103643_bb0355","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneurol.2009.304","article-title":"Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis","volume":"67","author":"Langer-Gould","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2024.103643_bb0360","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5152\/npa.2016.16979","article-title":"Serum prolactin levels in multiple sclerosis, Neuromyelitis Optica, and clinically isolated syndrome patients","volume":"53","author":"T\u00fcrko\u011flu","year":"2016","journal-title":"Noro Psikiyatr Ars"},{"key":"10.1016\/j.autrev.2024.103643_bb0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imm.13004","article-title":"Impact of sex hormones on immune function and multiple sclerosis development","volume":"156","author":"Ysrraelit","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2024.103643_bb0370","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-0041-1732490","article-title":"Prevalence of Macroprolactinemia in people detected to have hyperprolactinemia","volume":"13","author":"Sharma","year":"2021","journal-title":"J Lab Physicians"},{"key":"10.1016\/j.autrev.2024.103643_bb0375","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000499694","article-title":"Pitfalls in the diagnostic evaluation of hyperprolactinemia","volume":"109","author":"Vilar","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.autrev.2024.103643_bb0380","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejogrb.2014.10.013","article-title":"Importance of macroprolactinemia in hyperprolactinemia","volume":"183","author":"Kasum","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.autrev.2024.103643_bb0385","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03570.x","article-title":"Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers","volume":"71","author":"Hattori","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.autrev.2024.103643_bb0390","doi-asserted-by":"crossref","first-page":"346","DOI":"10.11613\/BM.2019.020706","article-title":"Optimizing laboratory defined macroprolactin algorithm","volume":"29","author":"\u0160ostari\u0107","year":"2019","journal-title":"Biochem Med"},{"key":"10.1016\/j.autrev.2024.103643_bb0395","first-page":"2012","article-title":"Macroprolactinemia: diagnostic, clinical, and pathogenic significance","author":"Shimatsu","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0400","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1677\/joe.1.06871","article-title":"Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia","volume":"190","author":"Hattori","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.autrev.2024.103643_bb0405","first-page":"3107","article-title":"Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex","volume":"82","author":"Hattori","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103643_bb0410","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/096120330101001107","article-title":"Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients","volume":"10","author":"Blanco-Favela","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103643_bb0415","first-page":"757","article-title":"Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus","volume":"10","author":"Blanco-Favelal","year":"2001"},{"key":"10.1016\/j.autrev.2024.103643_bb0420","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2265.2005.02243.x","article-title":"Clinical relevance of macroprolactin","volume":"62","author":"Gibney","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.autrev.2024.103643_bb0425","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1210\/jc.2004-1600","article-title":"Immunoglobulin G subclasses and prolactin (PRL) isoforms in Macroprolactinemia due to anti-PRL autoantibodies","volume":"90","author":"Hattori","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2024.103643_bb0430","first-page":"13","article-title":"IgG4 autoantibodies in organ-specific autoimmunopathies: reviewing class switching, antibody-producing cells, and specific immunotherapies","author":"Koneczny","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0435","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1440-1746.1995.tb01071.x","article-title":"Immunoglobulin G subclass distribution of human anticolon antibodies in ulcerative colitis","volume":"10","author":"Ohara","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2024.103643_bb0440","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF03350303","article-title":"Prolactin decrease and shift to a normal-like isoform profile during treatment with quinagolide in a patient affected by an invasive prolactinoma","volume":"20","author":"Guido","year":"1997","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.autrev.2024.103643_bb0445","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/EJE-13-0170","article-title":"Possible involvement of matrix metalloproteinase-3 in the pathogenesis of macroprolactinaemia in some patients with rheumatoid arthritis","volume":"169","author":"Adachi","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2024.103643_bb0450","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-0041-1732490","article-title":"Prevalence of Macroprolactinemia in people detected to have hyperprolactinemia","volume":"13","author":"Sharma","year":"2021","journal-title":"J Lab Physicians"},{"key":"10.1016\/j.autrev.2024.103643_bb0455","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1191\/096120398678920280","article-title":"Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia","volume":"7","author":"Lea\u00f1os","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103643_bb0460","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/096120330101001107","article-title":"Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients","volume":"10","author":"Blanco-Favela","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103643_bb0465","first-page":"21","article-title":"Correlation between systemic lupus erythematosus activity and plasma levels of monomeric prolactin and macroprolactin. Endocr Metab immune Disord drug","volume":"16","author":"Toffoli Ribeiro","year":"2016","journal-title":"Targets"},{"key":"10.1016\/j.autrev.2024.103643_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156253","article-title":"The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect","volume":"169","author":"Rasmi","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2024.103643_bb0475","first-page":"13","article-title":"The effect of prolactin on immune cell subsets involved in SLE pathogenesis","author":"Legorreta-Haquet","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0480","first-page":"5","article-title":"The dopaminergic system in autoimmune diseases","author":"Pacheco","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0485","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12016-009-8182-6","article-title":"Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models","volume":"40","author":"Saha","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0490","unstructured":"Anti-inflammatory Effects of Bromocriptine in a Patient with Autoimmune Polyglandular Syndrome Type 2 - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/24977964\/ (accessed July 15, 2024)."},{"key":"10.1016\/j.autrev.2024.103643_bb0495","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/316965","article-title":"The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China","volume":"2015","author":"Qian","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2024.103643_bb0500","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/sarh.2001.25482","article-title":"Bromocriptine in rheumatic and autoimmune diseases","volume":"31","author":"McMurray","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103643_bb0505","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1196\/annals.1423.031","article-title":"Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial","volume":"1110","author":"Jara","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2024.103643_bb0510","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/1440-1681.13678","article-title":"Bromocriptine therapy: review of mechanism of action, safety and tolerability","volume":"49","author":"Naz","year":"2022","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.autrev.2024.103643_bb0515","first-page":"e83","article-title":"Pemphigus vulgaris successfully treated with bromocriptine","volume":"23","author":"Lyadova","year":"2024","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.autrev.2024.103643_bb0520","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12026-016-8891-x","article-title":"Prolactin has a pathogenic role in systemic lupus erythematosus","volume":"65","author":"Jara","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2024.103643_bb0525","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/316965","article-title":"The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China","volume":"2015","author":"Qian","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2024.103643_bb0530","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/0961203313520059","article-title":"An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine","volume":"23","author":"Zhang","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103643_bb0535","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/cimm.1995.1058","article-title":"Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells","volume":"162","author":"Blank","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2024.103643_bb0540","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/1440-1681.13818","article-title":"Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2-STAT3 pathway","volume":"50","author":"Jiang","year":"2023","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.autrev.2024.103643_bb0545","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1196\/annals.1423.031","article-title":"Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial","volume":"1110","author":"Jara","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2024.103643_bb0550","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11481-019-09850-5","article-title":"Dopaminergic agents in rheumatoid arthritis","volume":"15","author":"Capellino","year":"2020","journal-title":"J NeuroImmune Pharmacol"},{"key":"10.1016\/j.autrev.2024.103643_bb0555","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T11:10:11Z","timestamp":1731237011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224001344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":111,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1568997224001344"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103643","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolactin's paradox: Friend, foe, or both in immune regulation?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103643"}}